Browse studies

Find your next paid study

27,375 recruiting studies available now

Emapalumab for the Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients

The investigators hypothesize that graft rejection after hematopoietic stem cell transplant (HSCT) is primarily driven by interferon gamma, and prophylactic in…

Hematopoietic Stem Cell TransplantationGraft Failure

Estimated

~$150 – $2,700

Actual pay is set by the research site.

Children's Hospital Medical Center, CincinnatiNCT07244419

EAGLE-HF is Part of a Multinational Group of Studies Titled; Screening for Early Heart Failure Diagnosis and Management in Primary Care or at Home Using Natriuretic Peptides and Echocardiography

EAGLE-HF (Early Assessment and initiation of GuideLine-directed Evidence-based management-HF) is a prospective single site study of a multinational, unblinded,…

Heart FailureSocioeconomic Adversity

Estimated

~$10 – $750

Actual pay is set by the research site.

The Cleveland ClinicNCT06849752

Phase 2

Multicenter, Randomized, Open-label, Active-controlled Study With a Blinded Assessor to Evaluate the Safety and Tolerability of Pivmecillinam Hydrochloride Versus Nitrofurantoin for the Treatment of Female Pediatric Subjects, 12 Years to Less Than 18 Years of Age, With Uncomplicated Urinary Tract Infections

Multicenter, Randomized, Open-label, Active-controlled Study with Blinded Assessor to Evaluate the Safety and Tolerability of Pivmecillinam Hydrochloride versu…

Uncomplicated Urinary Tract Infections

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Alembic TherapeuticsNCT07871968

Observational

Treating Passive Structures in Children With Developmental Language Disorder

The goal of this project is to compare the relative effectiveness of two novel treatments to improve the knowledge of the passive sentence structure of school-…

Developmental Language Disorders

Estimated

~$10 – $750

Actual pay is set by the research site.

Ohio UniversityNCT06932016

Phase 3

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

This trial plans to learn more about the effects of a medication, semaglutide, on cardiovascular function, kidney function, and insulin sensitivity in adults w…

Diabetes Mellitus, Type 1

Estimated

~$50 – $1,500

Actual pay is set by the research site.

University of Colorado, DenverNCT05819138

Phase 1

A Phase I, Open-Label, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of XNW28012 Monotherapy in the Treatment of Subjects With Metastatic Pancreatic Cancer

A Phase I, Open-Label, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of XNW28012 Monotherapy in …

Metastatic Pancreatic Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Evopoint Biosciences Inc.NCT07707674

Phase 2

Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable Squamous Cell Carcinoma of the Head and Neck: a Phase 2 Trial

This trial is to evaluate the safety and efficacy of ficerafusp alfa in combination with pembrolizumab prior to surgical resection in participants with resecta…

Head and Neck Squamous Cell Carcinoma (HNSCC)Squamous Cell Carcinoma of the Head and Neck

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Dana-Farber Cancer InstituteNCT07465276

Observational

Safety and Feasibility of Robotic Single-port (SP) Nipple Sparing Mastectomy: A Single Institution, Single Arm Pilot Trial

This is a single arm, single-center, prospective clinical trial designed to track the peri, post-operative and oncologic outcomes when utilizing the da-Vinci s…

Breast CancerHigh Risk of Breast Cancer

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Deborah Farr, MDNCT05245812

Observational

Virtual Group Resilient Living Program For Patients Living With Advanced Cancer

This study is a prospective, minimal risk, non-randomized, single-arm study to determine feasibility and assess effectiveness of a Virtual Group Resilient Livi…

Advanced Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT07659158

Phase 2

IZABRIGHT-Breast01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Treatment of Physician's Choice in Patients With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer (TNBC) or ER-low, HER2-negative BC Who Are Ineligible for Anti-PD1/PD-L1 Treatment

The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase in…

Breast Neoplasms

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Bristol-Myers SquibbNCT06926868

Observational

Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)

This is a prospective randomized, controlled, unblinded, interventional feasibility study to evaluate if showering with post operative drains in place leads to…

Postoperative Wound InfectionPostoperative ComplicationsSurgical Site Infection+1 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Sean DevittNCT04725916

Boehringer Laboratories Organ Retractor Device Study

This study aims to assess the safety and efficacy of an organ retraction device. The study is low risk as it is only being used in patients already undergoing …

Liver Retraction During Bariatric Surgery

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Boehringer Labs LLCNCT06754514